SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Orexo AB (publ) (ORXOF) .
本頁證實的標準:
- VALUE (0/100, 未通過) — 綜合估值評分低於60/100的通過門檻。
SharesGrow 綜合評分： 17/100 其中 0/7 項標準通過。
SharesGrow 7-Criteria Score
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
估值概覽 — ORXOF
估值倍數
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率3.05
EV/EBITDA0.0
每股數據
EPS (TTM)$-3.74
每股帳面價值$0.00
每股營收$0.75
每股自由現金流$0.00
收益率與內在價值
盈利收益率N/A
股息收益率0.00%
P/E Ratio & Earnings Yield
每股盈餘 (EPS) 歷史
| Year |
EPS（稀釋） |
營收 |
淨利潤 |
淨利潤率 |
| 2016 |
$0.84 |
$705.8M |
$29M |
4.1% |
| 2017 |
$0.67 |
$643.7M |
$23.2M |
3.6% |
| 2018 |
$3.93 |
$783.1M |
$137.9M |
17.6% |
| 2019 |
$6.20 |
$844.8M |
$219.1M |
25.9% |
| 2020 |
$-2.45 |
$663.6M |
$-84.4M |
-12.7% |
| 2021 |
$-6.51 |
$565M |
$-223.5M |
-39.6% |
| 2022 |
$-5.17 |
$624.3M |
$-177.6M |
-28.4% |
| 2023 |
$-3.73 |
$638.8M |
$-128.3M |
-20.1% |
| 2024 |
$-5.89 |
$590M |
$-203M |
-34.4% |
| 2025 |
$-3.74 |
$25.93M |
$-129.47M |
-499.2% |
